Pharmafile Logo
Pharmafocus logo
Advanced Search

ABPI

Showing 15 posts of 321 posts found.

Witty image

GSK’s Witty: ‘Drugs should be cheaper’

March 15, 2013
Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty

Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …

News

Pulse mistake costs Astellas

March 15, 2013
Medical Communications, Sales and Marketing ABPI, Astellas, PMCPA, pulse

A mistake by medical journal Pulse has landed Astellas Pharma in hot water with the PMCPA, enforcers of the ABPI …

News
ABPI image

ABPI supply chain warning

March 7, 2013
Manufacturing and Production, Sales and Marketing ABPI, API, EFPIA

The ABPI is warning of supply chain problems which may cause a bottleneck in UK pharma manufacture this summer. The …

News
ABPI image

ABPI moves to improve compliance

February 28, 2013
Sales and Marketing ABPI, NHS, alltrials, goldaccre, whiehead

The ABPI has fired its latest salvo in the clinical trial transparency debate by announcing it will appoint a new …

News
Roche image

Roche increases data access

February 27, 2013
Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche

Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …

News
bad pharma image

Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate

February 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead

In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …

Feature
Roche image

Roche censured for drunken conference antics

February 21, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA, Roche

The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …

News

VBP negotiations ‘opened up’

February 19, 2013
Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP

Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …

News

Lancet sparks agency row

February 15, 2013
Medical Communications, Sales and Marketing ABPI, Lancet, Luther Pendragon, Marlboro, Phillip Morris

Communications agency Luther Pendragon has parted company with cigarette firm Philip Morris after attention was drawn to the agency’s other …

News
GSK image

GSK announces AllTrials support

February 6, 2013
Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre

GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …

News
ABPI image

GP concern over GMC guidance

February 5, 2013
Sales and Marketing ABPI, GMC, GP, NHS

The ABPI has ‘warmly’ welcomed the new prescribing guidance from the General Medical Council – but GPs are far from …

News
NICE image

NICE hits back at ‘limited’ EC study

January 28, 2013
Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead

NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …

News
NICE image

The price of innovation

January 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, NICE, Rose, VBP

One of the strange paradoxes of our industry is that we have a very large number of new medicines in …

Feature

NICE publishes formulary guidance

December 19, 2012
Sales and Marketing ABPI, NHS, NICE, formularies, formulary

NICE has published its first guidance on good practice for those involved in working out what medicines should be made …

News
abpi_reception_right

Pharma applauds government strategy

December 11, 2012
Sales and Marketing ABPI, BIA, Cameron, Willetts

The ABPI and BioIndustry Association (BIA) have both welcomed the government’s update on its Strategy for UK Life Sciences, launched …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026